Flixene

Flixene is a trilaminate ePTFE graft engineered for early cannulation in dialysis access. It reduces time to first use compared with standard grafts. Unlike the bioabsorbable concept behind SelfWrap, Flixene remains permanently implanted. It is commercially distributed and positioned for patients needing rapid access creation. Relevance exists for those exploring all synthetic graft alternatives while VenoStent completes trials.